[British Medical Journal Publishing Group 25th EAHP Congress, 25thâ27th March 2020, Gothenburg, Sweden - ()] Section 5: Patient Safety and Quality assurance - 5PSQ-038â Safety of cyclin dependent kinase inhibitors in the treatment of breast cancer with positive hormonal receptors and negative human epidermal growth factor receptor 2
Rendón De Lope, L, Castillo-Martin, C, Alvarado Fernández, MD, Castillejo GarcÃa, R, Martinez Suarez, A, Cordero Ramos, JDOI:
10.1136/ejhpharm-2020-eahpconf.355
File:
PDF, 50 KB